BDNF and myeloid sarcoma: The pilot study by Sağir and colleagues highlighted the role of specific microRNAs, such as miR-132-3p, miR-106b-5p, and miR-19b-3p, in MS patients, notably examining their expression and regulation with BDNF production and the subsequent clinical outcome.